Islasertib

N/A

Report date: 2025/07/25 20:00:41
NME

Base Information

Drug NameIslasertib
Drug Alias NameLQT-1213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Sgk1 inhibitorsIon channels modulators
TargetsSerine/threonine-protein kinase Sgk1Ion channels
Therapy Area/IndicationsLong QT Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThryv Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThryv Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsLong QT Syndrome

Other Information

ATC CodeN/A
Related LinksN/A